Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma

Find Full text
Publication year
2019
Author(s)
Eggermont, Alexander M.M.
Blank, C.U.
Mandala, M.
Long, Georgina, V
Atkinson, V.
Dalle, S.
Koornstra, R.H.
Suciu, Stefan
Robert, Caroline
Source
European Journal of Cancer, 116, (2019), pp. 148-157
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/206244   https://hdl.handle.net/2066/206244
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.